Dr. John Leonard on When to Treat Patients With Follicular Lymphoma
John Leonard, MD, discusses the inefficacy of early treatment and treatment options for patients with follicular lymphoma. Leonard says the relapse rate for patients with follicular lymphoma is around 80%.
John Leonard, MD, medical oncologist, Weill Cornell Medicine and NewYorkPresbyterian Hospital, discusses the inefficacy of early treatment and treatment options for patients with follicular lymphoma. Leonard says the relapse rate for patients with follicular lymphoma is around 80%, though most patients with the malignancy will not pass away from their disease.
Leonard adds that data from recent studies also shows that early treatment of follicular lymphoma does not improve long-term outcomes. After relapse, Leonard says patients should be asking their doctors if they should be doing anything post-relapse and, if so, what the options are. Leonard says one thing doctors should be looking out for is symptomatic progression in patients with follicular lymphoma, at which point treatment should be considered.
Fedratinib Shows Promise in Chronic Neutrophilic Leukemia and MDS/MPN
January 20th 2025In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with myelodysplastic syndrome/myeloproliferative neoplasms and chronic neutrophilic leukemia.
Read More
